microneedles for medical point of care diagnostics and ... for medical point of care diagnostics and...

6
Microneedles for medical point of care diagnostics and drug delivery Ronen Polsky Department of Biosensors and Nanomaterials February 25, 2015 Sandia MedTech Showcase Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy’s National Nuclear Security Administration under contract DE-AC04-94AL85000. SAND2015-1388C

Upload: trinhtram

Post on 29-Apr-2018

219 views

Category:

Documents


4 download

TRANSCRIPT

Microneedles for medical point of care diagnostics and drug delivery

Ronen Polsky Department of Biosensors and

Nanomaterials February 25, 2015

Sandia MedTech Showcase Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin

Corporation, for the U.S. Department of Energy’s National Nuclear Security Administration under contract DE-AC04-94AL85000. SAND2015-1388C

Brief Technology Overview

Wearable Point of Care Diagnostic Device

Portable Handheld Medical Analyzer

Diagnostic/Drug Delivery Sense/Respond System

Underlying Technology 1. Minimally invasive microneedle

painlessly accesses interstitial fluid.

1

2

3

2. Biological analytes are extracted from the interstitial fluid through a hollow bore in the microneedle.

3. The analytes are drawn onto a microfluidic chip with embedded sensors for immediate analysis.

In contrast with current point of care diagnostic systems, the technology allows for real time analysis without transfer of fluids from patient to device and can easily be used by a non specialist

Continuously measure blood or interstitial fluid. Electronic readout and wireless transmission capabilities. Allows for measuring both short term and long term trends in

an individuals physiology. Multiplexed sensing platforms allows for site specific and

systemic monitoring of critical injuries and essential biological markers.

Analysis can be done outside of clinical visits reducing time

patients must spend in doctors offices.

Key Advantages

Differentiating factor from existing technology

The current state of the art wearable sensors today (e.g. fit bit) only make electrophysiological measurements such as heart rate, blood pressure, etc. Our technology allows for a suite of important biological markers to be measured that are currently only done in laboratory analysis.

The ability to make real time measurements of an individuals

physiology outside of a doctors office will make diagnosing and assessing medical conditions much easier and lead to better disease prevention.

There are currently no practical methods to make a diagnostic/

drug delivery device.

Commercial Applications Point of Care Diagnostics/Home

Health Care

Sports Medicine

Infectious Disease Treatment Defense of the Warfighter